118 related articles for article (PubMed ID: 24123026)
1. Therapeutic response of untreatable hepatocellular carcinoma after application of the immune modulators IL-2, BCG and melatonin.
Tomov B; Popov D; Tomova R; Vladov N; Den Otter W; Krastev Z
Anticancer Res; 2013 Oct; 33(10):4531-5. PubMed ID: 24123026
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
[TBL] [Abstract][Full Text] [Related]
6. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma.
Iwadou S; Nouso K; Kuwaki K; Kobayashi Y; Nakamura S; Tanaka H; Miyoshi K; Ohnishi H; Miyake Y; Shiraha H; Iwasaki Y; Shiratori Y; Yamamoto K
Liver Int; 2010 Aug; 30(7):1027-32. PubMed ID: 20492506
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
Lissoni P; Bolis S; Brivio F; Fumagalli L
Anticancer Res; 2000; 20(3B):2103-5. PubMed ID: 10928160
[TBL] [Abstract][Full Text] [Related]
9. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
11. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study.
Yan JJ; Shen F; Wang K; Wu MC
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):183-6. PubMed ID: 14607735
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
Hanna MG; Peters LC
Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
Lygidakis NJ; Konstantinidou T; Pothoulakis J
Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
[TBL] [Abstract][Full Text] [Related]
16. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
[TBL] [Abstract][Full Text] [Related]
18. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
19. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
20. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]